Document is current
Any future updates will be listed below
-
Authors
Kontogiannis, Vasileios https://orcid.org/0000-0002-9823-992X
Goromonzi, Farai
Both, Brigitte
Semrau, Frank
Branagan-Harris, Michael
Atkinson, Jowan
Roberts, Paul R.
Javanbakht, Mehdi
-
Funding
Funding for this research was provided by:
ZOLL Medical Corporation
- License Information
-
More Information
Article History
Accepted: 22 December 2024
First Online: 24 January 2025
Declarations
:
: This study is independent research funded by ZOLL Medical. The sponsor is aware of the content of the submitted material. F.G., B.B. and F.S. supported with literature search and insights into the medical background.
: V.K. and M.J. are employees of Optimax Access Ltd; M.B.H. and J.A. are employees of Device Access UK Ltd. Both Optimax Access and Device Access UK Ltd were commissioned by ZOLL to conduct this study. P.R. is a professor at University Hospital Southampton NHS Trust, was consulting ZOLL Medical at the time of conducting the work and received consulting fees for contributing to this study; F.G., B.B. and F.S. are employees of ZOLL Medical.
: All data used for this study are provided in the article or are publicly available as indicated by citations.
: Not applicable.
: Not applicable.
: Not applicable.
: The cost-effectiveness model was developed in Microsoft Excel 365 (Microsoft Corporation). Additional information about model programming is available from the corresponding author upon request.
: V.K. and M.J. developed the economic model and drafted the manuscript. All authors contributed to the study design or provided input on the model and read and approved the final draft of the manuscript.
